116 related articles for article (PubMed ID: 38387898)
41. Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines.
Wang Q; Ding W; Ding Y; Ma J; Qian Z; Shao J; Li Y
Oncotarget; 2017 Jun; 8(23):37594-37604. PubMed ID: 28410239
[TBL] [Abstract][Full Text] [Related]
42. [Regulatory Effect of MiR-543 on Proliferation and Apoptosis of Human Leukemia Cell Line K562 and Its Mechanism].
Sun L; Lu J; Li TT; Men LJ; Li CC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):763-768. PubMed ID: 31204929
[TBL] [Abstract][Full Text] [Related]
43. CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells.
Chang G; Zhang H; Wang J; Zhang Y; Xu H; Wang C; Zhang H; Ma L; Li Q; Pang T
Cancer Cell Int; 2013 Nov; 13(1):117. PubMed ID: 24257075
[TBL] [Abstract][Full Text] [Related]
44. Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia.
Karabay AZ; Koc A; Ozkan T; Hekmatshoar Y; Altinok Gunes B; Sunguroglu A; Buyukbingol Z; Atalay A; Aktan F
Hematology; 2018 Dec; 23(10):765-770. PubMed ID: 29945498
[TBL] [Abstract][Full Text] [Related]
45. Beta-catenin mutations are not observed in chronic myeloid leukemia.
Sercan Z; Pehlivan M; Gokturk D; Sercan HO
Tumori; 2009; 95(6):836-9. PubMed ID: 20210255
[TBL] [Abstract][Full Text] [Related]
46. [Effect of Meisoindigo on Wnt signal pathway in K562 and HL-60 cells].
Zuo MX; Li Y; Zhou JH; Wang HB; Chen XG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):579-82. PubMed ID: 20561405
[TBL] [Abstract][Full Text] [Related]
47. Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.
Shen Q; Liu S; Chen Y; Yang L; Chen S; Wu X; Li B; Lu Y; Zhu K; Li Y
J Hematol Oncol; 2013 Sep; 6():64. PubMed ID: 24004697
[TBL] [Abstract][Full Text] [Related]
48. Combined inhibition of β-catenin and Bcr-Abl synergistically targets tyrosine kinase inhibitor-resistant blast crisis chronic myeloid leukemia blasts and progenitors in vitro and in vivo.
Zhou H; Mak PY; Mu H; Mak DH; Zeng Z; Cortes J; Liu Q; Andreeff M; Carter BZ
Leukemia; 2017 Oct; 31(10):2065-2074. PubMed ID: 28321124
[TBL] [Abstract][Full Text] [Related]
49. Molecular mechanism of AQP3 in regulating differentiation and apoptosis of lung cancer stem cells through Wnt/GSK-3β/β-Catenin pathway.
Liu C; Liu L; Zhang Y; Jing H
J BUON; 2020; 25(4):1714-1720. PubMed ID: 33099905
[TBL] [Abstract][Full Text] [Related]
50. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
[TBL] [Abstract][Full Text] [Related]
51. [Study of apoptosis induced by indomethacin in chronic myeloid leukemia].
Tu C; Zhang G; Lu H
Zhonghua Xue Ye Xue Za Zhi; 1999 Jul; 20(7):362-5. PubMed ID: 11721434
[TBL] [Abstract][Full Text] [Related]
52. Effect of miR-26a targeting GSK-3β/β-catenin signaling pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion.
Gong DD; Yu J; Yu JC; Jiang XD
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7073-7082. PubMed ID: 31486509
[TBL] [Abstract][Full Text] [Related]
53. KIF23 promotes autophagy-induced imatinib resistance in chronic myeloid leukaemia through activating Wnt/β-catenin pathway.
Huang Y; Yuan C; Liu Q; Wang L
Clin Exp Pharmacol Physiol; 2022 Dec; 49(12):1334-1341. PubMed ID: 36066385
[TBL] [Abstract][Full Text] [Related]
54. Downregulation of Smad4 expression confers chemoresistance against imatinib mesylate to chronic myeloid leukemia K562 cells.
Zhang J; Zhang M; Liang Y; Liu M; Huang Z
Hematology; 2022 Dec; 27(1):43-52. PubMed ID: 34957936
[No Abstract] [Full Text] [Related]
55. [The Mechanism of Artesunate Combined with Cytarabine and/or Daunorubicin on the Apoptosis of MV4-11 MLL-rearranged Acute Myeloid Leukemia Cell Line].
Li JY; Xiong X; Wang DW; Zhang XY; Huang C; Zou LL; Zheng CF; Chen X; Tu CQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1724-1729. PubMed ID: 36476895
[TBL] [Abstract][Full Text] [Related]
56. [Growth inhibition and differentiation of imatinib-resistant chronic myeloid leukemia cell induced by cell differentiation agent in vitro].
Wang XD; Qiu L; Lu RZ; Chen LJ; Zhan ZM; Han BH; Zhang BL; Ma J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3399-405. PubMed ID: 18476538
[TBL] [Abstract][Full Text] [Related]
57. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
Zhang GS; Liu DS; Dai CW; Li RJ
Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
[TBL] [Abstract][Full Text] [Related]
58. Tetrandrine overcomes drug resistance mediated by bone marrow microenvironment by regulating the expression of P-glycoprotein in acute leukemia.
Zhou X; Jin N; Chen B
Hematology; 2022 Dec; 27(1):274-279. PubMed ID: 35192780
[No Abstract] [Full Text] [Related]
59. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
[TBL] [Abstract][Full Text] [Related]
60. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.
Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS
J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]